Duke Announces Olympic Sports Awards

Four Duke student-athletes were chosen by the Duke Sports Performance staff as the recipients of the Olympic Sports Performance Student-Athletes of the Year, and four others received Duke’s Live Strong Award for overcoming adversity in their pursuit to return to their sports.

Square 1 Bank Expands from Durham to Pacific Northwest

Durham-based Square 1, will move Rilus Graham, vice president of life sciences, to manage Square 1’s life sciences portfolio for the Northwest and the Rocky Mountains.

Durham Company Aims to Change Kidney Dialysis Process

Humacyte Inc.’s bioengineered blood vessel technology has received U.S. Food and Drug Administration approval for an investigational new drug application to conduct a multi-center U.S. clinical trial. The company hopes the vessels will help provide better access for dialysis in End-Stage Renal Disease patients.

Regado BioSciences Files $75 million IPO

Duke University spin-off Regado BioSciences has filed a $75 million initial public offering.

Quintiles Set to Go Public May 10

Durham's Quintiles is set to go public on May 10 with a range of $36 to $40 per share, the $750 million deal would make Quintiles the third-largest IPO so far this year.

Duke IGSP Director Elected to National Academy of Sciences

Huntington Willard, the founding director of the Duke Institute for Genome Sciences & Policy, has been elected to the National Academy of Sciences. Membership in the NAS is one of the highest honors given to a scientist in the United States.

David M. Rubenstein Gives $10 million to Duke

Duke University trustee David M. Rubenstein is giving $10 million to the Sanford School of Public Policy to endow graduate fellowships and undergraduate internships, and to create a fund that will enhance the school’s engagement with the policy world.